Dongwha Pharm.Co.Ltd (000020) — Working Capital to Net Assets Ratio
Dongwha Pharm.Co.Ltd (000020) has a Working Capital to Net Assets ratio of 3.7% as of December 2025. Working capital of ₩14.79 Billion (current assets of ₩217.62 Billion minus current liabilities of ₩202.83 Billion) is measured against net assets of ₩401.44 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Dongwha Pharm.Co.Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Dongwha Pharm.Co.Ltd Working Capital to Net Assets (2011–2025)
This chart shows how Dongwha Pharm.Co.Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 3.7%, reflecting working capital of ₩14.79 Billion against net assets of ₩401.44 Billion KRW. Check 000020 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Dongwha Pharm.Co.Ltd (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Dongwha Pharm.Co.Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Dongwha Pharm.Co.Ltd (000020) total market value.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.7% | ₩14.79 Billion | ₩401.44 Billion | ₩217.62 Billion | ₩202.83 Billion | ▼ -22.2 pp |
| 2024 | 25.8% | ₩103.80 Billion | ₩401.68 Billion | ₩237.81 Billion | ₩134.01 Billion | ▼ -6.5 pp |
| 2023 | 32.3% | ₩131.57 Billion | ₩407.06 Billion | ₩237.70 Billion | ₩106.13 Billion | ▼ -8.1 pp |
| 2022 | 40.4% | ₩153.12 Billion | ₩378.67 Billion | ₩227.53 Billion | ₩74.41 Billion | ▼ -2.6 pp |
| 2021 | 43.0% | ₩154.89 Billion | ₩360.13 Billion | ₩220.20 Billion | ₩65.31 Billion | ▼ -2.6 pp |
| 2020 | 45.6% | ₩156.40 Billion | ₩342.68 Billion | ₩222.74 Billion | ₩66.34 Billion | ▼ -14.1 pp |
| 2019 | 59.7% | ₩179.74 Billion | ₩300.87 Billion | ₩235.46 Billion | ₩55.71 Billion | ▲ +3.6 pp |
| 2018 | 56.2% | ₩167.09 Billion | ₩297.40 Billion | ₩227.89 Billion | ₩60.80 Billion | ▼ -2.3 pp |
| 2017 | 58.5% | ₩173.78 Billion | ₩296.94 Billion | ₩234.50 Billion | ₩60.72 Billion | ▲ +20.6 pp |
| 2016 | 38.0% | ₩96.04 Billion | ₩252.93 Billion | ₩151.49 Billion | ₩55.45 Billion | ▲ +9.3 pp |
| 2015 | 28.7% | ₩66.03 Billion | ₩230.12 Billion | ₩135.01 Billion | ₩68.98 Billion | ▲ +6.2 pp |
| 2014 | 22.5% | ₩51.63 Billion | ₩229.73 Billion | ₩120.55 Billion | ₩68.92 Billion | ▲ +3.4 pp |
| 2013 | 19.1% | ₩43.39 Billion | ₩227.23 Billion | ₩116.76 Billion | ₩73.37 Billion | ▲ +2.1 pp |
| 2012 | 17.0% | ₩38.64 Billion | ₩226.99 Billion | ₩121.24 Billion | ₩82.60 Billion | ▼ -2.3 pp |
| 2011 | 19.4% | ₩44.46 Billion | ₩229.62 Billion | ₩132.32 Billion | ₩87.86 Billion | — |